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Abstract 
 
European Union (EU) member states are bound to ensure accessible, good quality healthcare 
for all of their citizens. In 2018, Bosnia and Herzegovina has been named as a candidate for 
accession to EU membership as part of the “Strategy for the Western Balkans”. This scoping 
review identifies healthcare access issues in the country, aiming to inform policy-makers of 
challenges that may be faced in a possible membership application process and beyond. While 
the country has seemingly improved citizens’ healthcare access—as measured by the 
Healthcare Access and Quality Index—various specific problems remain unresolved. The main 
barrier to equal access appears to lie in the division of the healthcare system between the 
Federation of Bosnia and Herzegovina, the Republika Srpska, and the Brcko District, which 
also influences medicine availability and pricing. Although not necessarily systematic, studies 
further report distance from healthcare providers, alleged widespread corruption, 
discrimination of minorities and vulnerable populations, as well as vaccination gaps as 
problems in healthcare access for specific groups. While certainly not easy to realise, this 
scoping review concludes that possible solutions could include efforts to unify the healthcare 
and pricing system, and the implementation of the World Health Organization’s Essential 
Medicines List, as well as investigating and tackling corruption and stigma issues. 
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Introduction 
In February 2018, the European 
Commission (EC) announced their 
“Strategy for the Western Balkans” (1), 
featuring the discussion of a possible future 
European Union (EU) membership for 
Bosnia and Herzegovina (B&H). Since the 
Treaty of the Functioning of the European 
Union (TFEU) entered into force in 2009, 
one of the EU’s key objectives is a high 
level of human health protection (2) with 
the aim to provide EU citizens access to 
good quality healthcare and a wide range of 
evidence-based treatments. However, 
healthcare access has been named as one of 
the biggest problems in the healthcare 
system of B&H (3).  
 
 
Bosnia & Herzegovina: History and 
numbers 
B&H is located on the Balkan peninsula in 
South-eastern Europe, with an overall 
population of 3,507,017inhabitants, and a 
GDP of 18.055 Billion US$ (4). The 
country declared independence in 1992—
during the breakdown of Yugoslavia—but 
subsequently fell into a state of civil war 
and is still heavily affected by its aftermath, 
which included large-scale war crimes. The 
country features a very heterogeneous 
population (see Figure 1 - please note that 
this data is referring to the Federation of 
B&H [FBH], not the whole country).  
People who have fled the war and have 
returned afterwards face additional 
difficulties: returned men are more likely to 
be unemployed than those who stayed, 
while formerly displaced women are 
dropping out of the labour force more often 
than others of the same sex (5), and all 
groups are more vulnerable to corruption 
than those who stayed (6).  
The organisation of healthcare is split 
between the FBH, Republika Srpska (RS), 
ten autonomous cantons, and the Brcko 
District (BD) which makes it a 
heterogeneous structure split into 13 
components (8). Similarly, drug 
prescription systems are different between 
three entities (9). 
 
 
 
Figure 1. Ethnicities in the Federation of Bosnia and Herzegovina (7)
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Figure 2. Main stakeholders for drug prescription in the healthcare system of B&H 
[Source: adapted from Guzvic et al. (9)] 
 
 
 
 
 
While the peace treaty has been in effect for 
more than two decades, not all laws are in 
accordance with the conditions outlined in 
it. Long-term health consequences of 
deteriorated living standards, high 
unemployment, and economic insecurity 
include post-traumatic stress disorder 
(PTSD) and impaired psychological well-
being, not only among patients but also 
among their treating physicians (10). 
Likewise, adverse childhood experiences 
appear to be more common than in the EU 
- likely fostered by the post-war 
environment.  
A study on 400 hospital patients between 
18 and 24 years of age found that 48.7% of 
respondents had experienced at least one 
form of childhood adversity and the results 
“demonstrated associations between 
adverse experiences in childhood and the 
probability of engaging in health risk 
behaviour” (11). This environment and the 
often-related financial hardships further 
reduce access to healthcare (12). Other 
specific health challenges are physical war 
injuries. Since the beginning of the war, 
close to 8,000 landmine victims have been 
reported (13). B&H remains one of the 
most landmine infested countries in the 
European region. While most victims die 
instantly, survivors often have to undergo 
amputations, great physical pain, long 
hospitalisation periods, and can develop 
anxiety and/or depression.  
Data on patient safety in hospitals is scarce, 
but initial research found anecdotal 
evidence for an overall low perceived 
safety in three hospitals (14). A table 
containing the available health indicators 
can be found in the accompanying online 
repository (https://osf.io/axty3/). 
 
 
Access to health services; inequities, and 
inequalities 
Access to health services and healthcare is 
imperative for a healthy society. EU 
member states “have a clear mandate to 
ensure equitable access to high-quality 
health services for everyone living in their 
countries” (15). The EXPH clarifies that 
unmet healthcare needs should be 
addressed by allocating an appropriate 
amount of resources towards them. In that 
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sense, proper access to healthcare features 
the following eight characteristics: 
 
● Financial resources are linked to health 
needs 
● Services are affordable for everyone 
● Services are relevant, appropriate, and 
cost-effective 
● Facilities are within easy reach 
● There are enough health workers, with the 
right skills, in the right place 
● Quality medicine and medical devices are 
available at fair prices 
● People can use services when they need 
them 
● Services are acceptable to everyone 
This paper seeks to examine the status of 
healthcare access in the general population 
and vulnerable groups in B&H. Areas for 
improvement are identified, so that they 
may inform further specific research and 
recommendations for the EC as outlined in 
Art. 168 (2) in the TFEU should an 
accession process be put into motion. To do 
this, the country- and region-specific 
healthcare access problems are identified, 
inequities and inequalities are investigated, 
and compared to EU expectations (EXPH 
recommendations related to results can be 
found at: https://osf.io/zsq23).  
 
Methods 
Given the urgency of the issue, a scoping 
review was deemed to be the most fitting 
approach to identify healthcare access 
issues in B&H. While not fully exhaustive, 
scoping reviews allow for a faster 
(compared to systematic reviews) summary 
and dissemination of research findings, as 
well as the identification of research gaps 
(16), especially when the aim is to map 
broad topics. It has been argued that while 
there is no universally accepted precise 
definition of scoping reviews, their 
flexibility allows for the inclusion of more 
diverse evidence—such as grey literature—
and therefore yields great potential to 
inform practice, policy, education, and 
further research into specific aspects (17). 
An iterative approach based on a 
framework by Arksey and O’Malley (18) 
was employed. To identify relevant studies, 
PubMed was searched first, but this 
endeavour showed only limited results. A 
search in Google Scholar revealed a much 
greater amount of hits, but also clearly 
showed a massive number of unrelated 
results. The full number of results using 
[“healthcare access” AND “Bosnia”] (n = 
384), and an arbitrary number of results 
using [healthcare access AND Bosnia] (n = 
250 out of 16,100) were scanned and 
included if relevant. Based on these results, 
the identified topics were then again used in 
PubMed searches. Lastly, databases in 
Bosnian and Croatian language were 
searched for healthcare access issues in 
B&H to include local research and grey 
literature. For a detailed overview of search 
strings and results, please see 
https://osf.io/yn6ed/. A total of 14 scientific 
papers and policy documents were included 
in the full evidence review, based on the 
criterion that they investigate a healthcare 
access issue related to one or more 
populations in B&H. Results are portrayed 
in a narrative structure. Whenever possible, 
the investigated studies are also compared 
to the overall ratings of the Healthcare 
Access and Quality Index (HAQ) which is 
based on data from the Global Burden of 
Diseases, Injuries, and Risk Factors Study 
2015 (GBD) (19), building on six factors: 
 
i. Health expenditure per capita  
ii. Hospital beds (per 1000 
inhabitants) 
iii. Universal health coverage tracer 
index of 11 interventions 
iv. Physicians, nurses, and 
midwives (per 1000 inhabitants) 
v. Proportion of population with 
formal health coverage 
vi. Coverage index of three primary 
health-care interventions 
 
To calculate the HAQ, these were 
combined into a scale from 1 (lowest access 
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and quality) to 100 (highest possible access 
and quality) and measured per state and 
globally. 
 
Results 
 
Overall healthcare access and quality 
score 
The HAQ is generally improving globally 
and has even slightly improved in B&H 
during the war. It, therefore, may appear as 
if the war has hindered the development of 
overall access, but not thrown it back. 
However, the HAQ should not be taken as 
an indicator of equal healthcare access 
during 1990 and 1995, but merely 
interpreted as that the six outlined factors 
were invested in. When the war ended in 
1995, B&H had an overall HAQ of 62.1 
(compared to 60.9 in 1990) and has since 
constantly improved, up to a level of 78.2 
in 2015 (19). The highest score was in 
diphtheria [100] and the lowest in adverse 
effects of medical treatments [45]. For 
comparison: B&H’s EU neighbour Croatia 
had an overall HAQ of 70.4 in 1995 and 
improved to 81.6 in 2015.  
 
Access to healthcare in Bosnia & 
Herzegovina 
The HAQ may only serve as a point of 
reference for specific problems in order to 
check whether improving one of the six 
factors could serve as a starting point in 
solving the problem. In 2006, the uptake of 
basic healthcare insurance in B&H—which 
covers medical services at an appointed 
general practitioner or through specialist 
recommendation, as well as specific drug 
prescriptions—was 84%, ranging from 
63% in Hercegbosanski kanton to 93% in 
Sarajevo kanton, leaving around 380,000 
citizens uninsured (20).  
Coverage of basic healthcare for women in 
FBH and RS is lacking for 13–16% of the 
population, with the number rising up to 
60% in Roma women (21). In general, 
Roma women, impoverished women, 
individuals living in rural areas, and people 
with disabilities have been found to have 
the lowest rates of healthcare coverage.  
A low number of available gynaecologist 
practices and a lack of basic information 
about the process of acquiring health 
insurance are further hindering equal 
healthcare access. Employers do not always 
contribute regularly to workers healthcare 
schemes. This affected 27% of employees 
in 2015 in RS, with 16% receiving no 
payments at all towards their healthcare 
plan (21).  
 
Regional inequalities in health care access 
and provisions 
The division of the healthcare system 
between FBH, RS, and BD likely poses the 
greatest challenge in providing equal 
healthcare and healthcare access to citizens 
of B&H. Health policy making already 
proves to be extremely difficult because of 
a decentralised system and a large variety 
of decision makers in multiple regions (9). 
This also influences health technology 
assessment (HTA), which is needed to 
ensure that proper technology and 
methodology for screenings, diagnoses, and 
treatments are available. While HTA has 
been recognised in legislation, it has still 
not been introduced in full capacity due to 
lack of experts and education, and 
resistance from within the political 
environment (9).  
Drug prescription and reimbursement are 
decentralised and differ between regions, 
leading to discrepancies in pricing (Figure 
2). This causes an inequity regarding access 
to essential medicines, with prescribed 
drugs being 20% more expensive on 
average in RS compared to FBH (22). The 
highest price difference was found for 
atorvastatin—used in the treatment of 
dyslipidaemia and prevention of 
cardiovascular disease—which is 39% 
more expensive in RS than in the FBH. In 
general, prices in BD are 14% lower, 
compared to FBH. Prices and 
reimbursement for drugs also vary between 
cantons. Neighbours divided by a simple 
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canton border may have different access to 
prescriptions and reimbursements.  
Access to crucial medicine is further 
hindered by the limited number of drugs 
included on the FBH’s list of basic 
medicines (FBL). Compared to the WHO’ 
Essential Medicines List (EML) it is not a 
sufficient list of important drugs which 
should be reimbursed (23). Considering the 
scarce financial resources, the authors of 
the comparison conclude that the 
government should rather rely on the 
established, evidence informed EML. One 
example where this kind of inequity 
apparently has grave consequences is 
cancer treatment. Kurtovic-Kozaric et al. 
(24) claim that cancer patients in B&H 
either never receive the accurate therapy 
because it is missing from the list of 
government-reimbursed drugs, or they are 
put on a waiting list for one of the nine 
available drugs which are reimbursed - still 
causing a delay in treatment, with some 
treatments supposedly not available at all. 
 
Unmet healthcare needs 
Long distance to the nearest primary 
healthcare provider is problematic for 
citizens in various regions (3). About a 
quarter of the inhabitants live 1.5–5 
kilometres away from their nearest place of 
primary health care and 22% live more than 
5 kilometres away (20). This further 
disadvantages vulnerable populations, such 
as children, the elderly, or individuals with 
chronic ailments, who may be in special 
need of timely treatment or regular check-
ups (21). Rural areas also lack dental care 
specialists, compared to urban areas.  
Mandic Dokic (21) found that individuals 
with lower comprehension of written 
materials—with illiteracy being unequally 
distributed by gender (5.32% in men versus 
0.93% in women)—face a barrier in 
understanding medical conditions or 
treatment information written at a level too 
complex for them to understand.  
Healthcare access inequities and 
inequalities are often found for specific 
groups, especially minorities. In B&H, the 
number of Sinti and Roma is estimated to 
be around 35,000–40,000 (25). They are 2–
3 times more likely to report unmet health 
needs compared to non-Roma living 
nearby, especially when uninsured (26). 
Even when adjusted for “variation in 
gender, age, marital status, employment 
status, education, number of chronic 
conditions, health insurance status and 
geographical proximity to medical 
provider” (26) they are more likely to report 
unmet health needs in B&H specifically 
(Odds Ratio [OR]=1.44 adjusted for the 
aforementioned factors, OR=1.95 
unadjusted). The authors call for increased 
inclusion of Roma in the system and 
highlight the need for a detailed assessment 
of their needs within and outside of the 
health system.  
One of these unmet health needs is a gap in 
vaccination. An investigation (27) found 
that in Central and Eastern Europe, “Roma 
children have a lower probability of being 
vaccinated compared to non-Roma ([OR]= 
0.325). The odds of being vaccinated for a 
Roma child is 33.9% to that of a non-Roma 
child for DPT [diphtheria, pertussis, 
tetanus], 34.4% for Polio, 38.6% for MMR 
[measles, mumps, rubella] and 45.7% for 
BCG [tuberculosis]” (27). By comparing 
the means of vaccination coverage, the 
authors show that in B&H, the proportion 
of Roma children having received any 
vaccination is 14.8% lower compared to 
non-Roma. They are lower specifically by 
21.2% for BCG vaccine, 35.3% for Polio 
vaccine, 33.9% for DPT vaccine, and 
35.8% for MMR vaccine. This is especially 
worrying, as Roma tend to live in closed 
groups, making them less protected by the 
overall population’s herd immunity. The 
factors leading to low vaccination levels are 
relatively unknown but are likely related to 
a lack of access to healthcare in general, 
low level of education, and discrimination.  
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Financial barriers in healthcare access  
People formerly displaced through the war 
may return to their home country to find the 
healthcare system not to be welcoming. A 
series of semi-structured interviews 
conducted among 33 refugees who returned 
to B&H after long-term residence in 
Denmark provides an insight into their 
perception of the healthcare system (6). 
Interviewees reported widespread 
corruption and added that it influenced 
them even more negatively than it does 
people who stayed. Results indicate that 
corrupt physicians ask for larger bribes 
from returnees than from other citizens, 
facilitating a barrier to accessing various 
forms of healthcare. The situation is even 
worse for people suffering from chronic 
illnesses, as they are in need of frequent 
care.  
Focus group interviews with returnees (28) 
found that healthcare quality in general was 
perceived as extremely low, going as far as 
to state that “[n]one of the participants 
could see any bright future in the health-
care system” (28). While the authors 
suggest that educational activities for 
healthcare professionals—teaching them 
how to meet the needs of returned 
migrants—are needed, success is 
questionable in the light of the apparent 
existence of widespread corruption.  
One public opinion survey (3) found that 
many people believed that corruption 
occurs in hospitals (77% agreed), health 
centres (68%), and outpatient clinics 
(60%). Homo- and bisexual men are 
reportedly facing barriers in obtaining 
healthcare. Qualitative data obtained from 
12 in-depth interviews suggests that 
stigmatisation, discrimination, prejudice, 
and inequities this group faces in Bosnian 
& Herzegovinian society extends to the 
healthcare sector (29). While further, 
quantitative, investigation is needed to 
estimate the extent of this situation, 
Stojisavljevic and her colleagues (29) 
highlight the need for both educational 
trainings of professionals, as well as 
structural reform.  
This article features additional materials 
hosted on the Open Science Framework at 
https://osf.io/z8sd3/. 
 
Discussion  
The most important task goal B&H appears 
to be fostering re-unification of citizens and 
the healthcare system, whereas the latter is 
probably not possible without the former. If 
equity and equality in healthcare access 
ought to be improved as outlined by the 
EXPH (12), it is imperative that more 
treatments are made available and that they 
are available to all citizens, with medicine 
equally prescribed and reimbursed.  
A big step is an ordinance announced in 
January 2017 (30) by the Agency for 
Medicinal Products and Medical Devices, 
which is supposed to harmonise medication 
prices. However, its implementation has 
been described as insufficient and hindered 
by bureaucracy (3). Equity will also 
probably face a greater setback if B&H 
joined the EU: should the B&H health 
system stay similar to how it is now, some 
citizens are likely to choose medical travel 
to meet their health needs - an option that 
is, however, too expensive for most 
citizens. While Directive 2011/24/EU (31) 
constitutes a great opportunity to receive 
treatment which is not available in one’s 
own country, it is unlikely that—given the 
low income and overall GDP in B&H 
compared to the EU average—the majority 
of citizens will be able to profit from it.  
One straightforward option to work 
towards healthcare access equity would be 
to replace the national or regional medicine 
lists with the WHO’s EML and to adjust 
reimbursement schemes accordingly. If all 
three regions were to adopt the EML, this 
might also speed up the process of building 
a more unified healthcare and 
reimbursement system in general. Another 
possibly beneficial innovation is 
telemedicine. While it is currently only 
being adapted slowly in B&H, Naser et al. 
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(32) outline its potential, both in educating 
young professionals, as well as in 
treatment. However, the authors also note 
that its implementation is heavily reliant on 
investments in infrastructure and 
equipment, as well as a positive political 
climate welcoming it. While this seems 
highly ambitious, especially vulnerable 
groups could gain access to physicians of 
their choice more easily. Should B&H 
continue in its accession plans, the way will 
be a long one—especially in healthcare—
and will likely require some societal 
changes first. While many have called for 
more educational and change programmes, 
clear ideas on how these could look like or 
could be implemented are missing.  
As a scoping review, this investigation has 
a number of limitations by default. As it is 
supposed to serve as an overview of issues 
to address, there is no guarantee that it 
exhaustively covers all healthcare access 
issues in the country. The strength of 
evidence varies and is rather weak for 
certain areas; for example, while the 
vaccination gap in Roma is rather well 
researched—and immediate, specific 
action may be recommended—especially 
qualitative evidence for discrimination and 
bribery—although definitely issues to be 
investigated—are hard to quantify and their 
actual spread hard to know. Further, there is 
no indication to the extent of publication 
bias regarding the topic.  
In conclusion, both, the EU and B&H 
politics appear to be in need of addressing a 
multitude of healthcare access issues and 
establish solutions before accession seems 
sensible for both sides with regard to the 
goals set out by the EXPH. Should they 
succeed in this, however, citizens in B&H 
may be able to benefit from better access 
through the implementation of health law 
harmonisation, and hopefully also even 
cross-border healthcare at a later point. 
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